AFP and hepatocellular carcinoma: PIVKA-II and AFP-L3 showed the worst performance for identifying HCC.<h4>Conclusions</h4>GAAD and ASAP showed comparable or slightly superior performance to AFP, suggesting potential for screening strategies that should be confirmed in larger studies.